Decision-Making and Process

Some people need to “think out loud.” Others are eager to get right to the point. Toss in challenging schedules and countless communication platforms at our fingertips — a reality amplified by today's hybrid and virtual work environments — and the decision doesn’t get any easier. And, of course, this is unlikely to get better as more “content” is created in seconds due to the proliferation of AI.

The first edition of "Connecting the Dots" was published on September 29, 2017. Since Sue Nemetz penned that inaugural piece, 12 authors from our team have contributed their insight, experience, and perspective on the biopharma industry.

Biopharma companies need to balance many critical priorities, especially those that are pre-commercial.

As summer winds down and vacations (sadly) come to an end, it’s a natural time to shift focus toward the close of the calendar year. Business leaders should prepare their organizations for a landscape that will be shaped by rapid technological changes, evolving market demands, and increasing global challenges.

The energy was palpable at the 2025 Medical Affairs Professional Society (MAPS) Global Annual Meeting. Conversations were expansive, workshops immersive, and the questions being asked were less about what Medical Affairs can do and more about how it must evolve to meet the future.

In our biopharma world, we frequently hear the term “Key Business Questions (KBQs).” And while it’s often thrown around as a buzzword (or buzz phrase, in this case), it has quite a bit of practical value when its full depth is explored.

The value of New Product Planning (NPP) is often overlooked, but it plays a crucial role in the success of drug development projects. By incorporating NPP early in the process, you can increase the likelihood of commercial success and minimize risks.

How do we think about biopharma annual planning differently? The analogy we will draw on is fitness trackers and apps—built for mindfulness and exercise—these devices and apps create a habit for daily (weekly, monthly, etc.) self-challenges.

In the biopharma industry, the Target Product Profile (TPP) is a critical tool for guiding the development and commercialization of new drugs.

In the ever-evolving biopharma landscape, success hinges not just on innovation but also on a clear roadmap guiding clinical and commercial development.